Why Is Iovance Therapeutics (IOVA) Stock Up 35% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

With Iovance Therapeutics gaining FDA approval for its novel skin cancer therapeutic, IOVA stock is proving the bears wrong.

The post Why Is Iovance Therapeutics (IOVA) Stock Up 35% Today? appeared first on InvestorPlace.

• ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.